白云山阿托伐他汀钙化学原料药上市申请获批

北京商报
Yesterday

北京商报讯(记者王寅浩)3月6日,白云山发布公告称,近日公司分公司白云山化学制药厂收到国家药品监督管理局签发的阿托伐他汀钙《化学原料药上市申请批准通知书》。该药物为羟甲基戊二酰辅酶A还原酶抑制剂,主要用于治疗原发性高胆固醇血症和其他相关疾病。(文章来源:北京商报)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10